HK1203837A1 - Immunogenic hpv l2-containing vlps and related compositions and methods hpv l2 vlp - Google Patents

Immunogenic hpv l2-containing vlps and related compositions and methods hpv l2 vlp

Info

Publication number
HK1203837A1
HK1203837A1 HK15104584.7A HK15104584A HK1203837A1 HK 1203837 A1 HK1203837 A1 HK 1203837A1 HK 15104584 A HK15104584 A HK 15104584A HK 1203837 A1 HK1203837 A1 HK 1203837A1
Authority
HK
Hong Kong
Prior art keywords
hpv
vlp
methods
immunogenic
related compositions
Prior art date
Application number
HK15104584.7A
Other languages
English (en)
Chinese (zh)
Inventor
Bryce Chackerian
David Peabody
Ebenezer Tumban
Original Assignee
Stc Unm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stc Unm filed Critical Stc Unm
Publication of HK1203837A1 publication Critical patent/HK1203837A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/18011—Details ssRNA Bacteriophages positive-sense
    • C12N2795/18111—Leviviridae
    • C12N2795/18141—Use of virus, viral particle or viral elements as a vector
    • C12N2795/18142—Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/18011—Details ssRNA Bacteriophages positive-sense
    • C12N2795/18111—Leviviridae
    • C12N2795/18141—Use of virus, viral particle or viral elements as a vector
    • C12N2795/18143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK15104584.7A 2012-01-12 2015-05-14 Immunogenic hpv l2-containing vlps and related compositions and methods hpv l2 vlp HK1203837A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261585839P 2012-01-12 2012-01-12
PCT/US2013/020960 WO2013106525A1 (en) 2012-01-12 2013-01-10 Immunogenic hpv l2-containing vlps and related compositions and methods

Publications (1)

Publication Number Publication Date
HK1203837A1 true HK1203837A1 (en) 2015-11-06

Family

ID=48781889

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15104584.7A HK1203837A1 (en) 2012-01-12 2015-05-14 Immunogenic hpv l2-containing vlps and related compositions and methods hpv l2 vlp

Country Status (8)

Country Link
EP (1) EP2802349B1 (pt)
JP (1) JP6185932B2 (pt)
CN (1) CN104159606A (pt)
AU (1) AU2013207962B2 (pt)
BR (1) BR112014017242A8 (pt)
CA (1) CA2861021A1 (pt)
HK (1) HK1203837A1 (pt)
WO (1) WO2013106525A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9549976B1 (en) 2012-11-16 2017-01-24 Stc.Unm Affinity selection of Nipah and Hendra virus-related vaccine candidates from a complex random peptide library displayed on bacteriophage virus-like particles
US10258698B2 (en) 2013-03-14 2019-04-16 Modernatx, Inc. Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
JP2016530294A (ja) 2013-09-03 2016-09-29 モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． キメラポリヌクレオチド
US20160194368A1 (en) 2013-09-03 2016-07-07 Moderna Therapeutics, Inc. Circular polynucleotides
EP3043815A4 (en) 2013-09-12 2017-06-14 Stc.Unm Malaria vaccine
EP3052521A1 (en) 2013-10-03 2016-08-10 Moderna Therapeutics, Inc. Polynucleotides encoding low density lipoprotein receptor
WO2017136400A1 (en) * 2016-02-02 2017-08-10 Stc. Unm Vlp-based vaccines for targeting staphylococcus aureus secreted virulence factors
EP3454889A2 (fr) 2016-05-13 2019-03-20 Flash Therapeutics Particule virale pour le transfert d'arns, notamment dans les cellules impliquées dans la réponse immune
JP7285220B2 (ja) 2017-05-18 2023-06-01 モデルナティエックス インコーポレイテッド 連結したインターロイキン－１２（ｉｌ１２）ポリペプチドをコードするポリヌクレオチドを含む脂質ナノ粒子
AU2018342997C1 (en) 2017-09-29 2024-07-04 Deutsches Krebsforschungszentrum Cutaneous papilloma virus vaccine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9113809D0 (en) * 1991-06-26 1991-08-14 Cancer Res Campaign Tech Papillomavirus l2 protein
GB9420146D0 (en) * 1994-10-06 1994-11-23 Cancer Res Campaign Tech Papillomavirus vaccine
US7320793B2 (en) * 2001-01-19 2008-01-22 Cytos Biotechnology Ag Molecular antigen array
CA2575997A1 (en) * 2004-08-04 2006-03-16 Cytos Biotechnology Ag Carrier conjugates of gnrh-peptides
WO2011100234A2 (en) * 2010-02-09 2011-08-18 Stc.Unm Immunogenic hpv l2-containing vlps and related compositions, constructs, and therapeutic methods

Also Published As

Publication number Publication date
JP2015504897A (ja) 2015-02-16
CA2861021A1 (en) 2013-07-18
BR112014017242A8 (pt) 2017-07-04
AU2013207962A1 (en) 2014-08-07
WO2013106525A1 (en) 2013-07-18
CN104159606A (zh) 2014-11-19
EP2802349A4 (en) 2015-08-26
EP2802349B1 (en) 2017-12-06
BR112014017242A2 (pt) 2017-06-13
AU2013207962B2 (en) 2017-07-20
EP2802349A1 (en) 2014-11-19
JP6185932B2 (ja) 2017-08-23

Similar Documents

Publication Publication Date Title
HK1203837A1 (en) Immunogenic hpv l2-containing vlps and related compositions and methods hpv l2 vlp
HK1231412A1 (zh) 免疫原性組合物
HK1202442A1 (en) Vaccines against hpv hpv
EP2536428A4 (en) UNIVERSAL INFLUENZA VACCINES WITH VIRUSIC PARTICLES
IL229419B (en) Heat-stable vaccines and methods for their preparation
RS56157B1 (sr) Glikoproteinske čestice nalik virusu (vlp) besnila
ZA201503927B (en) Immunogenic composition
SG11201404447WA (en) Immunogenic composition
IL238079A0 (en) Immunogenic preparation
SG11201500979RA (en) Immunogenic composition
GB201223342D0 (en) Immunogenic composition
HK1209326A1 (en) Reassortant btv and ahsv vaccines btv hpv
GB201218660D0 (en) Immunogenic composition
EP2694102A4 (en) PROCESS FOR IMPROVED VACCINE IMMUNOGENICITY
EP2870238A4 (en) COMPOSITIONS AND METHODS ASSOCIATED WITH VIRAL VACCINES
EP2742139A4 (en) IMMUNOGENIC COMPOSITIONS AND ASSOCIATED METHODS
AU2012902151A0 (en) Immunogenic vaccines and uses thereof
AU2011903217A0 (en) Immunogenic compositions and methods therefor
IL226187B (en) Virus-like glycoprotein particles in rabies
GB201204968D0 (en) Immunogenic composition
GB201204851D0 (en) Immunogenic composition